Neogenesis and development of the high endothelial venules that mediate lymphocyte trafficking

Cancer Science

Volumn 101, Issue 11, 2010, Pages 2302-2308

  Hayasaka, Haruko ^a,b   Taniguchi, Kanako ^a,b   Fukai, Shoko ^a,b   Miyasaka, Masayuki ^a,b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR CXCR4; CXCL13 CHEMOKINE; ENZYME; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GROWTH FACTOR; L SELECTIN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; PERIPHERAL NODE ADDRESSIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; UNCLASSIFIED DRUG;

BASEMENT MEMBRANE; CANCER IMMUNOTHERAPY; CELL STRUCTURE; ENDOTHELIUM; ENDOTHELIUM CELL; HIGH ENDOTHELIAL VENULE; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE MIGRATION; LYMPHOID TISSUE; MICROVASCULATURE; MOLECULE; NEOBIOGENESIS; ONTOGENY; ORGANOGENESIS; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATION; REVIEW; STEM CELL;

ANIMALS; CELL ADHESION; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; HUMANS; LYMPH NODES; LYMPHOCYTES; MUCINS; PEYER'S PATCHES; SIGNAL TRANSDUCTION;

EID: 77958548603     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01687.x     Document Type: Review

References (56)

1. Von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol 2003; 3: 867-78.
2. Miyasaka M, Tanaka T. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat Rev Immunol 2004; 4: 360-70.
3. Bajenoff M, Egen JG, Koo LY et al. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 2006; 25: 989-1001.
4. Mebius RE, Dowbenko D, Williams A, Fennie C, Lasky LA, Watson SR. Expression of GlyCAM-1, an endothelial ligand for L-selectin, is affected by afferent lymphatic flow. J Immunol 1993; 151: 6769-76.
5. Mebius RE, Breve J, Duijvestijn AM, Kraal G. The function of high endothelial venules in mouse lymph nodes stimulated by oxazolone. Immunology 1990; 71: 423-7.
6. Liao S, Ruddle NH. Synchrony of high endothelial venules and lymphatic vessels revealed by immunization. J Immunol 2006; 177: 3369-79.
7. Kumar V, Scandella E, Danuser R, et al. Global lymphoid tissue remodeling during a viral infection is orchestrated by a B cell-lymphotoxin-dependent pathway. Blood 2010; 115: 4624-6.
8. Cupedo T, Jansen W, Kraal G, Mebius RE. Induction of secondary and tertiary lymphoid structures in the skin. Immunity 2004; 21: 655-67.
9. Anderson ND, Anderson AO, Wyllie RG. Specialized structure and metabolic activities of high endothelial venules in rat lymphatic tissues. Immunology 1976; 31: 455-73.
10. Lasky LA, Singer MS, Dowbenko D et al. An endothelial ligand for L-selectin is a novel mucin-like molecule. Cell 1992; 69: 927-38.
11. Baumheter S, Singer MS, Henzel W et al. Binding of L-selectin to the vascular sialomucin CD34. Science 1993; 262: 436-8.
12. Kanda H, Tanaka T, Matsumoto M et al. Endomucin, a sialomucin expressed in high endothelial venules, supports L-selectin-mediated rolling. Int Immunol 2004; 16: 1265-74.
13. Umemoto E, Tanaka T, Kanda H et al. Nepmucin, a novel HEV sialomucin, mediates L-selectin-dependent lymphocyte rolling and promotes lymphocyte adhesion under flow. J Exp Med 2006; 203: 1603-14.
14. Maly P, Thall A, Petryniak B et al. The α(1, 3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell 1996; 86: 643-53.
15. Yeh JC, Hiraoka N, Petryniak B et al. Novel sulfated lymphocyte homing receptors and their control by a Core1 extension β1, 3-N-acetylglucosaminyltransferase. Cell 2001; 105: 957-69.
16. x, an L-selectin ligand displayed by CD34. Immunity 1999; 11: 79-89.
17. Berg EL, McEvoy LM, Berlin C, Bargatze RF, Butcher EC. L-selectin-mediated lymphocyte rolling on MAdCAM-1. Nature 1993; 366: 695-8.
18. Yang BG, Tanaka T, Jang MH, Bai Z, Hayasaka H, Miyasaka M. Binding of lymphoid chemokines to collagen IV that accumulates in the basal lamina of high endothelial venules: its implications in lymphocyte trafficking. J Immunol 2007; 179: 4376-82.
19. Nakasaki T, Tanaka T, Okudaira S et al. Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions. Am J Pathol 2008; 173: 1566-76.
20. Kanda H, Newton R, Klein R, Morita Y, Gunn MD, Rosen SD. Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat Immunol 2008; 9: 415-23.
21. Kashiwazaki M, Tanaka T, Kanda H et al. A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions. Int Immunol 2003; 15: 1219-27.
22. Girard JP, Baekkevold ES, Yamanaka T, Haraldsen G, Brandtzaeg P, Amalric F. Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization. Am J Pathol 1999; 155: 2043-55.
23. Usui T, Murai T, Tanaka T et al. Characterization of mac25/angiomodulin expression by high endothelial venule cells in lymphoid tissues and its identification as an inducible marker for activated endothelial cells. Int Immunol 2002; 14: 1273-82.
24. Nagakubo D, Murai T, Tanaka T et al. A high endothelial venule secretory protein, mac25/angiomodulin, interacts with multiple high endothelial venule-associated molecules including chemokines. J Immunol 2003; 171: 553-61.
25. + high endothelial venule cells (HEV) and identification of a leucine-rich HEV glycoprotein as a HEV marker. J Immunol 2002; 168: 1050-9.
26. Mebius RE. Organogenesis of lymphoid tissues. Nat Rev Immunol 2003; 3: 292-303.
27. + cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 1997; 7: 493-504.
28. Van De Pavert SA, Olivier BJ, Goverse G et al. Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation. Nat Immunol 2009; 10: 1193-9.
29. Adachi S, Yoshida H, Kataoka H, Nishikawa S. Three distinctive steps in Peyer's patch formation of murine embryo. Int Immunol 1997; 9: 507-14.
30. Hashi H, Yoshida H, Honda K et al. Compartmentalization of Peyer's patch anlagen before lymphocyte entry. J Immunol 2001; 166: 3702-9.
31. Cupedo T, Vondenhoff MF, Heeregrave EJ et al. Presumptive lymph node organizers are differentially represented in developing mesenteric and peripheral nodes. J Immunol 2004; 173: 2968-75.
32. Webster B, Ekland EH, Agle LM, Chyou S, Ruggieri R, Lu TT. Regulation of lymph node vascular growth by dendritic cells. J Exp Med 2006; 203: 1903-13.
33. Drayton DL, Bonizzi G, Ying X, Liao S, Karin M, Ruddle NH. IκB kinase complex α kinase activity controls chemokine and high endothelial venule gene expression in lymph nodes and nasal-associated lymphoid tissue. J Immunol 2004; 173: 6161-8.
34. Carragher D, Johal R, Button A et al. A stroma-derived defect in NF-κB2-/- mice causes impaired lymph node development and lymphocyte recruitment. J Immunol 2004; 173: 2271-9.
35. Tumanov A, Kuprash D, Lagarkova M et al. Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues. Immunity 2002; 17: 239-50.
36. Drayton DL, Liao S, Mounzer RH, Ruddle NH. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol 2006; 7: 344-53.
37. Kratz A, Campos-Neto A, Hanson MS, Ruddle NH. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J Exp Med 1996; 183: 1461-72.
38. Drayton DL, Ying X, Lee J, Lesslauer W, Ruddle NH. Ectopic LTαβ directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase. J Exp Med 2003; 197: 1153-63.
39. Hjelmstrom P, Fjell J, Nakagawa T, Sacca R, Cuff CA, Ruddle NH. Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am J Pathol 2000; 156: 1133-8.
40. Ngo VN, Korner H, Gunn MD et al. Lymphotoxin α/β and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med 1999; 189: 403-12.
41. Luther SA, Lopez T, Bai W, Hanahan D, Cyster JG. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 2000; 12: 471-81.
42. Luther SA, Bidgol A, Hargreaves DC et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 2002; 169: 424-33.
43. Ansel KM, Ngo VN, Hyman PL et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000; 406: 309-14.
44. Mebius RE, Bauer J, Twisk AJ, Breve J, Kraal G. The functional activity of high endothelial venules: a role for the subcapsular sinus macrophages in the lymph node. Immunobiology 1991; 182: 277-91.
45. Baekkevold ES, Jahnsen FL, Johansen FE et al. Culture characterization of differentiated high endothelial venule cells from human tonsils. Lab Invest 1999; 79: 327-36.
46. Browning JL, Allaire N, Ngam-Ek A et al. Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function. Immunity 2005; 23: 539-50.
47. Mebius RE, Streeter PR, Breve J et al. The influence of afferent lymphatic vessel interruption on vascular addressin expression. J Cell Biol 1991; 115: 85-95.
48. Drayson MT, Ford WL. Afferent lymph and lymph borne cells: their influence on lymph node function. Immunobiology 1984; 168: 362-79.
49. Duijvestijn AM, Rep M, Hendriks HR, Kraal G. Functional capacities of high endothelial venules appear not to be controlled by recirculating lymphocytes. Immunobiology 1990; 180: 295-307.
50. Lacorre DA, Baekkevold ES, Garrido I et al. Plasticity of endothelial cells: rapid dedifferentiation of freshly isolated high endothelial venule endothelial cells outside the lymphoid tissue microenvironment. Blood 2004; 103: 4164-72.
51. Baekkevold ES, Roussigne M, Yamanaka T et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 2003; 163: 69-79.
52. Carriere V, Roussel L, Ortega N et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA 2007; 104: 282-7.
53. Izawa D, Tanaka T, Saito K et al. Expression profile of active genes in mouse lymph node high endothelial cells. Int Immunol 1999; 11: 1989-98.
54. Schrama D, Thor Straten P, Fischer WH et al. Targeting of lymphotoxin-α to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue. Immunity 2001; 14: 111-21.
55. Kirk CJ, Hartigan-O'Connor D, Mule JJ. The dynamics of the T-cell antitumor response: chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodally. Cancer Res 2001; 61: 8794-802.
56. Dieu-Nosjean MC, Antoine M, Danel C et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008; 26: 4410-7.